This inventor holds 3 USPTO granted patents and 1 published patent application. Top assignee: Immunocore Limited. Active years: 2022-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022-2024
Title: The Innovative Contributions of Ronan Pádraic O'Dwyer
Introduction
Ronan Pádraic O'Dwyer is a notable inventor based in Abingdon, GB. He has made significant contributions to the field of immunotherapy, particularly through his work on T cell receptors. With a total of 3 patents to his name, O'Dwyer's innovations are paving the way for advancements in cancer treatment.
Latest Patents
O'Dwyer's latest patents focus on T cell receptors (TCRs) that bind the HLA-A*02 restricted peptide SLLQHLIGL, derived from the germline cancer antigen PRAME. These TCRs may include non-natural mutations within the alpha and/or beta variable domains relative to a native PRAME TCR. The TCRs developed by O'Dwyer are particularly suitable for use as novel immunotherapeutic reagents for the treatment of malignant diseases.
Career Highlights
O'Dwyer is currently associated with Immunocore Limited, a company that specializes in developing innovative therapies for cancer. His work has been instrumental in advancing the understanding and application of T cell receptors in immunotherapy.
Collaborations
Some of O'Dwyer's notable coworkers include Philip William Addis and Nicole Joy Bedke. Their collaborative efforts contribute to the ongoing research and development in the field of immunotherapy.
Conclusion
Ronan Pádraic O'Dwyer is a prominent figure in the realm of immunotherapy, with his innovative patents and contributions significantly impacting cancer treatment. His work continues to inspire advancements in medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile